By upregulating serum IgA, IgG and IgM levels, enlarging the population of CD4+ T cells and balancing the ratio of CD4+/CD8+ cells, HQH significantly lowered the rate of reinfection in severe pediatric patients of Mycoplasma pneumonia (13). The gene discussed is CD40LG; the disease is Mycoplasma pneumoniae pneumonia.